Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study

Giovannoni, Gavin; ...; Drulovic, Jelena S; ...; (broj, koautora 22)

Results

eNauka > Results > Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study

Title:	Efficacy and safety of ocrelizumab in primary progressive multiple sclerosis, including older patients and those with more advanced disease (ORATORIO-HAND): a multicentre, double-blind, randomised, placebo-controlled, phase 3b study
Authors:	Giovannoni, Gavin; ...; Drulovic, Jelena S ; ...; (broj, koautora 22)
Issue Date:	2026
Publication:	LANCET
ISSN:	0140-6736 Lancet Search Idenfier
Type:	Article
Collation:	vol. 407 br. 10544 str. 2195-2207
WoS-ID:	001786667800001
URI:	https://enauka.gov.rs/handle/123456789/1046414
Project:	F Hoffmann-La Roche
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	21a+M21a+

6
WEB OF SCIENCE^TM

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.